Acaricidal effects of fluazuron (2.5 mg/kg) and a combination of fluazuron (1.6 mg/kg) + ivermectin (0.63 mg/kg), administered at different routes, against Rhipicephalus (Boophilus) microplus parasitizing cattle
Nenhuma Miniatura disponível
Data
2015-06-01
Autores
Costa Gomes, Lucas Vinicius [UNESP]
Zanetti Lopes, Welber Daniel [UNESP]
Cruz, Breno Cayeiro [UNESP]
Teixeira, Weslen Fabricio [UNESP]
Felippelli, Gustavo [UNESP]
Maciel, Willian G. [UNESP]
Bichuette, Murilo Abud [UNESP]
Ruivo, Maycon A.
Alcantara Colli, Marcos Henrique
Carvalho, Rafael Silveira
Título da Revista
ISSN da Revista
Título de Volume
Editor
Elsevier B.V.
Resumo
The present study aimed to evaluate the acaricidal efficacy of fluazuron (2.5 mg/kg), administered as a pour-on, in comparison to an injectable formulation containing fluazuron (1.6 mg/kg) + ivermectin (0.63 mg/kg), against Rhipicephalus (Boophilus) microplus in naturally and experimentally infested cattle. Two studies were conducted with different tick strains, one with artificial infestations (Stall Test, using leight animals per group) and one with natural infestations (utilizing ten animals per group): In both studies, the animals were randomized, according to average tick counts performed on days -3, -2 and -1, into four groups: T01, negative control (saline solution); T02, pour-on fluazuron (2.5 mg/kg); T03: subcutaneous fluazuron (1.6 mg/kg) + ivermectin (0.63 mg/kg); and T04 subcutaneous ivermectin (0.63 mg/kg). Based on obtained results, and considering the utilized tick strains, it was possible to conclude that the pour-on fluazuron (2.5 mg/kg) formulation demonstrated high acaricidal efficacy, with protection periods ranging from 49 to 77 days against Rhipicephalus (Boophilus) microplus. On the other hand, for the injectable fluazuron (1.6 mg/kg) + ivermectin (0.63 mg/kg) formulation, it was not possible to observe elevated anti-R. (B.) microplus effect on both artificial and experimental infestation studies. Results observed for this combination were similar or inferior to those obtained by subcutaneous ivermectin (0.63 mg/kg). Future studies with this formulation containing fluazuron (1.6 mg/kg) + ivermectin (0.63 mg/kg), regarding pharmacokinetic and/or bioavailability profiles, or even studies analyzing both this active principles separately, are needed, seeking to better understand the effects of such combination against Rhipicephalus (Boophilus) microplus parasitizing cattle. (C) 2015 Elsevier Inc. All rights reserved.
Descrição
Palavras-chave
Engorged females, Fluazuron, Injectable route, Ivermectin, Rhipicephalus (Boophilus) microplus
Como citar
Experimental Parasitology. San Diego: Academic Press Inc Elsevier Science, v. 153, p. 22-28, 2015.